IRSS, Burkina Faso   Report issue

Academic/Hospital Phase 3
Founded: Burkina Faso

Organization Overview

First Clinical Trial
2009
NCT00941785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

IRSS, Burkina Faso and LSHTM, UK

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 5